Home » Topics » BioWorld Science

BioWorld Science
RSS

BeiGene reports preliminary phase II topline data for tislelizumab in classical Hodgkin's lymphoma

July 23, 2018

Wakamoto completes phase II trial of WP-1303

July 23, 2018

UCT-943, a next-generation PI4K inhibitor antimalarial agent: Preclinical profile

July 23, 2018

Aevi presents AEVI-004, novel co-crystal version of AEVI-001

July 23, 2018

AT: all bad for platelets

July 23, 2018

First biomarker for liver injury from biologic

July 23, 2018

The Yang to KRAS' Yin?

July 23, 2018

Sending live phages after deadly lung infections

July 23, 2018

Membrane findings point to new antimalarial strategies

July 23, 2018

Gritstone Oncology to test GRANITE-001 with Opdivo and Yervoy

July 23, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 10, 2026.
‘Target-high but uptake-defective’ state identified in ADC resistance
BioWorld
Separate research teams have reported new insights into resistance mechanisms to the antibody-drug conjugate (ADC) Padcev (enfortumab vedotin, Astellas Pharma...
Ionis, AZ shares down on unexpected Wainua flop in cardiomyopathy
BioWorld
News of the unexpected phase III failure of the gene silencing drug Wainua (eplontersen) in the treatment of transthyretin-mediated amyloid cardiomyopathy sent...
FENS 2026: Shedding light on the sheddome
BioWorld
At the recently opened FENS Forum 2026 in Barcelona – the Federation of European Neuroscience Societies’ flagship congress and Europe’s largest neuroscience...
FENS 2026: Next-gen biologics take on brain disease
BioWorld
Whether by fine-tuning neurotransmitter signaling or silencing disease-associated genes, emerging biologic therapies are reshaping neuroscience drug development,...